End-To-End Services from a Single Facility
Our Pessano, Italy site is a 220,000 sq ft (20.4k sq m) facility providing clinical and commercial scale manufacturing
The facility’s expanded R&D capabilities provide customizable, flexible systems that expedite formulation & process development services. These expanded services allow for both clinical & commercial manufacturing at the Pessano facility, streamlining development timelines for our global customers.
Pessano Site Overview
- 24/5 Work Schedule
- Clinical and Commercial scale manufacturing
- Manufacturing of clinical batches
- Organic solvent capabilities
- Serves US, European, and Japanese markets
- Key Capabilities:
- Granules
- Plain tablets
- Film- or sugar- coated tablets
- Hard-gelatin or HPMC capsules
- Microcaps®
- Microtabs
- MMTS™ Minitabs
- Diffucaps®
- Extruded – spheronized
- Granules
- Controlled substances (DPR 309/90)
- Safety standard obtained (ISO 45001)
Faster Development Timelines With Reduced API
- Non-GMP Small Scale Laboratory
- Provides additional early-stage non-GMP development capacity
- Produces smaller batches using less active pharmaceutical ingredients
- Allows projects to initiate immediately
- Reduces development timelines
- Mirrors Adare’s pilot & production capabilities
- Integrated R&D validated through to commercial manufacturing
- Full-service capabilities for even the most complex product creation
- Flexible business model customized to fit your program
- In-house regulatory affairs team with proven global track record
– Microcaps® (organic or aqueous) – Granules, Diffucaps® (fluid-bed coating), Extruded-Spheronized bulk – Tablets, capsules
– Diffucaps® (pan coating) – MMTSTM Minitabs, Microtabs,Tablets containing enzymes (controlled area)
Our Pessano, Italy site is just one part of our global network of sites, providing integrated CDMO solutions for customers around the globe. Contact us today to speak with one of our drug delivery experts about how Adare’s broad spectrum of CDMO capabilities can help make your next project a success.
